Access Pharmaceuticals, Hunter-Fleming deal

AKC and Hunter-Fleming will use AKC's vitamin B12 oral drug delivery technology to improve the oral bioavailability of Hunter-Fleming's oligotropin (HF 0420). Oligotropin has completed Phase Ia trials...